Merck reported EUR10.34B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Adidas EUR 2.49B 2.31B Sep/2026
Adyen EUR 338.31M 155.04M Jun/2026
Akzo Nobel EUR 5.5B 1000K Sep/2026
Alcon AG USD 4.69B 41M Sep/2026
Amadeus IT EUR 2.53B 8.7M Sep/2026
AstraZeneca USD 28.8B 2.79B Sep/2026
BASF EUR 17.31B 1.51B Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
Beiersdorf EUR 110M 7M Jun/2026
Covestro EUR 1.67B 408M Dec/2025
Danone EUR 10.68B 609M Jun/2026
Fresenius EUR 10.51B 952M Sep/2026
Fresenius Medical Care EUR 5.15B 676.78M Sep/2026
Genmab DKK 4.96B 28M Jun/2026
Givaudan CHF 4.19B 448M Dec/2025
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
GRIFOLS EUR 8.69B 1.52B Sep/2026
Henkel EUR 3.26B 1.88B Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Infineon EUR 6.44B 83M Sep/2026
Lakefront Biotherapeutics EUR 1.83M 2.94M Sep/2026
Linde USD 20.59B 734M Sep/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.34B 866M Sep/2026
Novartis USD 38.38B 893M Sep/2026
Philips EUR 6.98B 669M Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 16.28B 1.63B Sep/2026
UCB EUR 2.18B 634M Dec/2025